Sangamo Therapeutics SGMO
$ 1.91
-2.6%
Quarterly report 2024-Q3
added 11-12-2024
Sangamo Therapeutics EV/EBITDA Ratio 2011-2024 | SGMO
Annual EV/EBITDA Ratio Sangamo Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-6.78 | -14.7 | -7.63 | -13.1 | -28.9 | -3.19 | -7.69 | -32.7 | -42.3 | -22.4 | -4.26 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-3.19 | -42.3 | -16.7 |